Fellows will receive a competitive stipend and benefit package, including comprehensive health insurance.
Employer will assist with relocation costs.
Internal Number: Booth #7867 B
Alexion, in collaboration with MCPHS, offers a unique fellowship program to promote the role of the Doctor of Pharmacy (PharmD) within the biopharmaceutical industry. A fellow gains extensive experiences through various practical activities in both industry and academic settings, which could enhance the potential for accelerated career development.
Global Regulatory Affairs (GRA) is responsible for the design and execution of innovative and regulatory strategies that drive the advancement and approval of their products to serve patients. Through a partnership with external stakeholders, GRA colleagues make a positive contribution to the global regulatory environment and provide ongoing support of products that span the development cycle, with the highest degree of compliance.
The Alexion GRA fellowship is designed to provide the fellow with hands-on exposure to a multitude of specialties within GRA and across various products and therapeutic areas. The fellow will have the opportunity to build a broad, robust foundation as a regulatory professional while directly contributing to the development of Alexion’s products and the patients they serve. Throughout the program, the fellow will have the ability to tailor the program to their unique interests and overall professional development needs. This program will provide the fellow with the opportunity to:
Serve as the Regulatory representative at cross-functional meetings by providing helpful insight and contributing feedback and guidance on various documents and projects
Support and/or drive the planning, updating, development, review, approval, and submission of various documents critical to the success of Regulatory initiatives
Lead cross-functional teams through appropriate processes to comply with Regulatory driven commitments and represent Regulatory for US and global health authority interactions
Gain a solid understanding of the current Regulatory landscape, including relevant guidances, enforcement actions, and laws, rules, and/or regulations.
To be considered for an interview at Midyear, please register for both ASHP Midyear and PPS and then complete a fellowship application on the MCPHS SMapply application portal. Visit mcphs.smapply.io
The portal will open on October 3, 2022 at 8:00am EST
Please DO NOT request an interview within PPS. Our recruitment teams will contact qualified candidates via PPS to schedule interviews.
ASHP attendance is not required but highly recommended for in-person interviews.
Before ASHP Midyear Clinical Meeting
Applicants must upload the following application materials to the online portal by November 11, 2022:
Letter of intent
Unofficial college transcript
Contact information of three references for their recommendations.
Incomplete applications WILL NOT be reviewed. ASHP Clinical Midyear Meeting interviews CANNOT be scheduled until these materials have been submitted. Please keep in mind that this is a competitive process and applicants are encouraged to complete their applications as soon as possible.
Three recommendations must be submitted by the three provided contacts no later than December 1st
The MCPHS Biopharmaceutical Industry fellows will be selected on a nationally competitive basis, with interviews at the American Society of Health Systems Pharmacists (ASHP) Midyear meeting.
Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy at the commencement of the program.
Candidates must have strong written and verbal communication skills and a strong interest in pursuing a career within the biopharmaceutical industry.
All candidates must have authorization to work in the United States throughout the duration of the one or two-year fellowship. No visa sponsorship will be provided.
Alexion, AstraZeneca Rare Disease, is the group within AstraZeneca focused on rare diseases, created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. As a leader in rare diseases for nearly 30 years, Alexion is focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines. Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on hematology, nephrology, neurology, metabolic disorders, cardiology, ophthalmology, and acute care. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries.
MCPHS provides an academic environment to guide and support fellows toward a successful career in the biopharmaceutical industry. As a private institution with a history of specializing in health sciences, MCPHS offers programs that embody scholarship, professional service, and community outreach.
Through MCPHS, the fellow will have the opportunity to gain teaching and research experience in an academic setting. MCPHS faculty and company... program leaders mentor fellows according to their scholarly and professional interests throughout the two-year program.
As an adjunct instructor at MCPHS, the fellow may have the opportunity to:
•Develop, coordinate, and teach courses
•Co-precept pharmacy students on advanced experiential rotations
•Create and publish scholarly research and/or review articles
•Present research at scientific and clinical meetings
•Participate in professional development seminars with other fellows and residents from MCPHS-affiliated programs